Academic Journal

Odd-Chain Dicarboxylic Acid Feeding Produces a Glutaric Aciduria Type 1-Like Metabolic Signature in Mice.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Odd-Chain Dicarboxylic Acid Feeding Produces a Glutaric Aciduria Type 1-Like Metabolic Signature in Mice.
Συγγραφείς: Richert AC; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Zhang Y; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Bharathi SS; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Hernandez A; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Dodatko T; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Bons J; The Buck Institute for Research on Aging, Novato, California, USA., Roundtree KE; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Stauffer B; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Yu C; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Schilling B; The Buck Institute for Research on Aging, Novato, California, USA., Houten SM; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Goetzman ES; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Πηγή: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2025 Nov 15; Vol. 39 (21), pp. e71215.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE
Imprint Name(s): Publication: 2020- : [Bethesda, Md.] : Hoboken, NJ : Federation of American Societies for Experimental Biology ; Wiley
Original Publication: [Bethesda, Md.] : The Federation, [c1987-
Ιατρικοί όροι (MeSH): Amino Acid Metabolism, Inborn Errors*/metabolism , Amino Acid Metabolism, Inborn Errors*/pathology , Glutaryl-CoA Dehydrogenase*/deficiency , Glutaryl-CoA Dehydrogenase*/metabolism , Dicarboxylic Acids*/metabolism , Dicarboxylic Acids*/administration & dosage , Brain Diseases, Metabolic*/metabolism , Brain Diseases, Metabolic*/chemically induced , Brain Diseases, Metabolic*/pathology, Glutarates/metabolism ; Mitochondria/metabolism ; Peroxisomes/metabolism ; Animals ; Mice ; Male ; Mice, Inbred C57BL
Περίληψη: Glutaric aciduria type-1 (GA1) is an inherited mitochondrial neurometabolic disorder with a poorly understood pathogenesis and unmet medical needs. GA1 can be diagnosed via its hallmark biochemical signature consisting of glutaric aciduria, 3-hydroxyglutaric aciduria, and increased plasma glutarylcarnitine. These glutaryl-CoA-derived metabolites are thought to originate solely in the mitochondria. Here, we demonstrate that wild-type mice fed an 11-carbon odd-chain dicarboxylic acid (undecanedioic acid, DC11) recreate the biochemical phenotype of GA1. Odd-chain dicarboxylic acids like DC11 are not present in food but can arise from several endogenous processes, such as lipid peroxidation and fatty acid ω-oxidation. DC11 is chain-shortened in peroxisomes to glutaryl (DC5)-CoA, which then gives rise to the GA1-like pattern of DC5 metabolites in urine, tissues, and blood. Glutaric acid released from peroxisomes during DC11 chain-shortening can enter mitochondria for reactivation by the enzyme succinyl-CoA:glutarate-CoA transferase (SUGCT) and become substrate for glutaryl-CoA dehydrogenase (GCDH), the enzyme that is deficient in GA1. Our data provide proof-of-concept that the generation of dicarboxylic acids by ω-oxidation, which is stimulated during the same catabolic states known to trigger acute encephalopathy in GA1, may exacerbate disease by increasing the glutaryl-CoA substrate load in mitochondria.
(© 2025 Federation of American Societies for Experimental Biology.)
Σχόλια: Update of: bioRxiv. 2025 Feb 16:2025.02.13.637994. doi: 10.1101/2025.02.13.637994.. (PMID: 39990440)
References: Nat Protoc. 2017 Jun;12(6):1110-1135. (PMID: 28471460)
Biochem Med. 1975 Jan;12(1):12-21. (PMID: 1137568)
J Inherit Metab Dis. 2021 Nov;44(6):1343-1352. (PMID: 34515344)
JIMD Rep. 2024 Aug 27;65(6):433-441. (PMID: 39512438)
Nat Commun. 2016 Jan 12;7:8992. (PMID: 26754106)
Proc Jpn Acad Ser B Phys Biol Sci. 2013;89(8):370-82. (PMID: 24126285)
Biochim Biophys Acta. 2012 Sep;1822(9):1397-410. (PMID: 22465940)
Biomolecules. 2024 Sep 15;14(9):. (PMID: 39334926)
Metabolism. 1991 Jul;40(7):676-82. (PMID: 1870421)
Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165720. (PMID: 32057943)
Brain. 2006 Apr;129(Pt 4):899-910. (PMID: 16446282)
J Biol Chem. 2005 Nov 18;280(46):38125-32. (PMID: 16141203)
Cell Metab. 2014 Apr 1;19(4):605-17. (PMID: 24703693)
J Lipid Res. 2012 Jul;53(7):1296-303. (PMID: 22534643)
Biochemistry. 2002 Jan 29;41(4):1274-84. (PMID: 11802727)
Biomolecules. 2024 Nov 26;14(12):. (PMID: 39766215)
J Vis Exp. 2010 May 21;(39):. (PMID: 20495529)
Hum Mol Genet. 2002 Feb 15;11(4):347-57. (PMID: 11854167)
Cell Mol Life Sci. 2021 Jul;78(14):5631-5646. (PMID: 34110423)
Methods Mol Biol. 2014;1156:157-74. (PMID: 24791987)
Fluids Barriers CNS. 2014 Jul 24;11:15. (PMID: 25077029)
Hum Mutat. 1998;12(3):141-4. (PMID: 9711871)
Genet Med. 2021 Jan;23(1):13-21. (PMID: 32981931)
Sci Rep. 2021 Sep 29;11(1):19300. (PMID: 34588557)
Am J Hum Genet. 2008 Nov;83(5):604-9. (PMID: 18926513)
Brain. 2011 Jan;134(Pt 1):157-70. (PMID: 20923787)
J Neurochem. 2006 May;97(3):899-910. (PMID: 16573641)
Int J Mol Sci. 2023 Mar 03;24(5):. (PMID: 36902339)
Pediatr Res. 1986 Jan;20(1):62-6. (PMID: 3945517)
Mol Genet Metab. 2010;100 Suppl 1:S88-91. (PMID: 20299259)
Open Biol. 2022 Sep;12(9):220179. (PMID: 36128717)
Biochim Biophys Acta. 1986 May 21;876(3):515-25. (PMID: 3707982)
J Biol Chem. 2015 Jul 24;290(30):18671-7. (PMID: 26070565)
Brain. 2009 Jul;132(Pt 7):1764-82. (PMID: 19433437)
Nat Commun. 2017 Aug 21;8(1):291. (PMID: 28827567)
J Biol Chem. 1999 Aug 27;274(35):24461-8. (PMID: 10455107)
FEBS J. 2006 May;273(9):2012-22. (PMID: 16640564)
Cell Mol Life Sci. 2008 Mar;65(6):982-90. (PMID: 18264800)
J Biol Chem. 2021 Jan-Jun;296:100622. (PMID: 33811861)
Mol Genet Metab. 2011 Sep-Oct;104(1-2):93-106. (PMID: 21820344)
Biochem Biophys Res Commun. 2020 Jun 18;527(1):162-166. (PMID: 32446361)
FASEB J. 2019 Mar;33(3):4355-4364. (PMID: 30540494)
J Am Soc Nephrol. 2024 Feb 1;35(2):135-148. (PMID: 38044490)
JIMD Rep. 2022 Jun 14;63(4):379-387. (PMID: 35822093)
J Mol Evol. 2009 Aug;69(2):176-93. (PMID: 19639238)
Mol Cell Proteomics. 2012 Jun;11(6):O111.016717. (PMID: 22261725)
FEBS Lett. 1992 Sep 28;310(2):193-6. (PMID: 1397271)
Cell Metab. 2017 Apr 4;25(4):823-837.e8. (PMID: 28380375)
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Oct 15;1097-1098:101-110. (PMID: 30218917)
FEBS Lett. 2011 May 6;585(9):1317-21. (PMID: 21477586)
Adv Exp Med Biol. 2020;1299:55-70. (PMID: 33417207)
J Lipid Res. 2004 Jun;45(6):1104-11. (PMID: 15060085)
Proteomes. 2022 May 23;10(2):. (PMID: 35645376)
Biochim Biophys Acta. 2008 Jun;1782(6):385-90. (PMID: 18348873)
J Inherit Metab Dis. 2019 Jan;42(1):117-127. (PMID: 30740735)
Pediatr Res. 1983 Feb;17(2):171-6. (PMID: 6402754)
Biochem J. 2023 May 15;480(9):607-627. (PMID: 37140888)
ACS Chem Biol. 2024 Jul 19;19(7):1544-1553. (PMID: 38915184)
J Inherit Metab Dis. 1992;15(2):220-3. (PMID: 1527989)
Brain. 2005 Apr;128(Pt 4):711-22. (PMID: 15689364)
J Inherit Metab Dis. 2021 Nov;44(6):1419-1433. (PMID: 34564857)
J Clin Invest. 2024 Apr 30;134(12):. (PMID: 38687608)
Biochim Biophys Acta. 1993 Feb 8;1141(1):81-9. (PMID: 8435437)
Atherosclerosis. 2010 Apr;209(2):449-54. (PMID: 19880116)
Mol Genet Metab. 2021 Feb;132(2):139-145. (PMID: 33483254)
J Clin Invest. 2007 Nov;117(11):3258-70. (PMID: 17932566)
Biochim Biophys Acta. 1993 Jun 12;1168(2):190-8. (PMID: 8504154)
Ann Neurol. 2018 May;83(5):970-979. (PMID: 29665094)
Mol Cell Proteomics. 2017 Dec;16(12):2296-2309. (PMID: 29070702)
Metabolism. 1989 Jul;38(7):655-61. (PMID: 2739576)
Mol Genet Metab. 2010 Oct-Nov;101(2-3):178-82. (PMID: 20732827)
Sci Transl Med. 2023 Apr 19;15(692):eadf4086. (PMID: 37075130)
JIMD Rep. 2019 Mar 26;47(1):30-34. (PMID: 31240164)
J Inherit Metab Dis. 2020 Nov;43(6):1154-1164. (PMID: 32567100)
Mol Genet Metab Rep. 2020 Nov 25;25:100666. (PMID: 33299796)
Mol Genet Metab. 2020 Nov;131(3):325-340. (PMID: 33069577)
Grant Information: T34 GM136493 United States GM NIGMS NIH HHS; OD028654 HHS | National Institutes of Health (NIH); HD112518 HHS | National Institutes of Health (NIH); DK120531 HHS | National Institutes of Health (NIH); R01 DK090242 United States DK NIDDK NIH HHS; R01 HD103602 United States HD NICHD NIH HHS; R01 HD118270 United States HD NICHD NIH HHS; R01 HD112518 United States HD NICHD NIH HHS; HD118270 HHS | National Institutes of Health (NIH); HD103602 HHS | National Institutes of Health (NIH); DK090242 HHS | National Institutes of Health (NIH)
Contributed Indexing: Keywords: dicarboxylic acids; glutaric acidemia I; glutaryl‐coenzyme A; mitochondria; peroxisomes; succinyl‐coenzyme A
Substance Nomenclature: EC 1.3.8.6 (Glutaryl-CoA Dehydrogenase)
0 (Dicarboxylic Acids)
0 (Glutarates)
H849F7N00B (glutaric acid)
SCR Disease Name: Glutaric Acidemia I
Entry Date(s): Date Created: 20251106 Date Completed: 20251106 Latest Revision: 20260916
Update Code: 20260916
PubMed Central ID: PMC13066932
DOI: 10.1096/fj.202502381R
PMID: 41196119
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1530-6860
DOI:10.1096/fj.202502381R